Skip to main content
Menu
  • Meet Idylla
    • Idylla Platform
    • Oncology Tests
      • Idylla MSI Test – Now 510(k) cleared!
  • Oncology
    • Oncology Tests
    • Oncologist
      • Idylla for colorectal cancer
    • Pathologist
  • Oncology Research
    • Research Assays
      • Idylla POLE Mutation Assay
      • Idylla IDH1-2 Mutation Assay Kit
      • Idylla GeneFusion Assay
      • Idylla EGFR Mutation Assay
      • Idylla KRAS Mutation Assay
      • Idylla NRAS-BRAF-EGFR-S492R Mutation Assay
      • Idylla BRAF Mutation Assay
      • Idylla ctEGFR Mutation Assay
      • Idylla ctKRAS Mutation Assay
      • Idylla ctNRAS-BRAF-EGFR S492R Mutation Assay
    • IIS Information
    • Publications
    • On-Demand Webinars
  • Partnering
  • Press & Events
    • Press Releases
    • Events
  • About Us
    • Team
    • Careers
    • Download Center
    • Contact
  • IFU
  • Secure area
  • Global
  • United States
Open/Close
  • Search
  • Contact us
  • 1-844-443-9552
  • Subscribe to news
  • Global
  • United States
Biocartis Breast Cancer WEBINAR - Watch now
INTERVIEW with Dr. Tabetha Sundin, AstraZeneca - READ MORE  
Idylla IDH1-2 Mutation Assay Kit - Innovative. Fast. Easy.
Idylla MSI Test - 510(k) cleared!
Idylla GeneFusion Assay - Improved NTRK performance!

Biocartis

Menu
  • Meet Idylla
    • Idylla Platform
    • Oncology Tests
      • Idylla MSI Test – Now 510(k) cleared!
  • Oncology
    • Oncology Tests
    • Oncologist
      • Idylla for colorectal cancer
    • Pathologist
  • Oncology Research
    • Research Assays
      • Idylla POLE Mutation Assay
      • Idylla IDH1-2 Mutation Assay Kit
      • Idylla GeneFusion Assay
      • Idylla EGFR Mutation Assay
      • Idylla KRAS Mutation Assay
      • Idylla NRAS-BRAF-EGFR-S492R Mutation Assay
      • Idylla BRAF Mutation Assay
      • Idylla ctEGFR Mutation Assay
      • Idylla ctKRAS Mutation Assay
      • Idylla ctNRAS-BRAF-EGFR S492R Mutation Assay
    • IIS Information
    • Publications
    • On-Demand Webinars
  • Partnering
  • Press & Events
    • Press Releases
    • Events
  • About Us
    • Team
    • Careers
    • Download Center
    • Contact

Our mission & vision

Biocartis’ vision is to enable personalized medicine for patients around the world through universal access to molecular testing. Our mission is to make molecular testing actionable, easy, fast and suitable for any lab.

267633s_1bioc-world_mission_vision.jpg
Meet Idylla

Meet Idylla

Idylla™ - A revolutionary, fully automated system that makes molecular testing easy, fast and suitable for any lab!

Learn more
header_2 women_no biocartis

Oncology

Molecular biomarker results in only 3 hours!

THINK IDYLLA™

Learn more
Research Biocartis

Oncology Research

Biocartis encourages the research into new and emerging uses of different biomarkers.

Learn more
Partnering Biocartis

Partnering

Biocartis believes in the power of collaboration and has partnership programs with pharmaceutical and diagnostic or biomarker companies

Learn more

Select your area of expertise

Oncologist

For Oncologists

Molecular biomarker results in only 3 hours for fast decision-making! THINK IDYLLA

Learn more
Pathologist

For Pathologists

IdyllaTM - A revolutionary, fully-automated, real-time PCR based molecular testing system designed to offer accurate results in only 3 hours. It makes molecular testing easy, fast and suitable for any lab.

Learn more
  • Idylla Platform
  • Oncology Tests
  • Research Assays
  • Events
  • Careers

Biocartis US Inc.

2 Pierce Place, Suite 1510

Itasca, IL 60143

Phone: +1 (844) 443-9552

customerserviceUS@bio­cartis.com

 

Biocartis Global

  • Subscribe to news
  • Contact us
  • Request demo
  • Download center
  • LinkedIn
  • Facebook
  • YouTube
  • Twitter
  • Purchase conditions
  • Cookie policy
  • Privacy policy
  • Terms of use
© 2024 Biocartis Created by O2 Agency